How it should be taken
It comes as a tablet which contains abacavir, lamivudine and zidovudine.(300 mg / 150 mg / 300 mg) to take by mouth, with or without food.
Dosage & When it is to be taken
The recommended oral dose is one tablet twice daily. Weight should be at least 40 Kg.
When it is not to be taken (Contraindications)
Why it is prescribed (Indications)
This combination medication contains a nucleoside reverse transcriptase inhibitor (NRTI), prescribed for HIV-1 infection. It works by preventing human immunodeficiency virus (HIV) cells multiplication in your body.
Category C :
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Warnings and Precautions
Caution should be exercised in patients with history of kidney problems, heart disease, high blood pressure, high cholesterol, diabetes, bone marrow depression, muscle disorders, smoking, alcoholism, hepatitis B infection, breathing problem, nerve disorders, obesity, poor immunity, abdominal pain, diarrhea, nausea, vomiting, cough, sore throat, fever, fatigue, rash, any allergy, who are taking other medications, during pregnancy and breastfeeding.
It may cause dizziness, do not drive a car or operate machinery while taking this medication.
It should not be used in children.
It does not stop the spread of infection to others; avoid sexual contact, sharing of needles, injection supplies.
Store it at controlled room temperature (15° to 30°C).